Search This Blog

Thursday, May 7, 2026

Ironwood Q1 profit of $40.8 m on $106.5 m revenue, guides 2026 revenue to $450-$475 m

 

Ironwood Pharmaceuticals posts Q1 profit of $40.8 million on $106.5 million revenue, guides 2026 revenue to $450-$475 million

  • Q1 2026 net income reported as $41 million, with LINZESS U.S. sales up 97% YoY
  • Ironwood Pharmaceuticals affirms its 2026 guidance after releasing Q1 2026 financial results

Lantheus wins FDA approval for PYLARIFY TruVu and beats Q1 2026 estimates

 

Lantheus wins FDA approval for PYLARIFY TruVu and beats Q1 2026 estimates with revenue $377.3M, adjusted EPS $1.46

  • FDA approval of PYLARIFY TruVu was disclosed in a recent Lantheus SEC filing.
  • Q1 2026 revenue of $377.3 million exceeded the Zacks consensus estimate of $358.1 million.
  • Q1 2026 adjusted EPS of $1.46 beat the Zacks consensus estimate of $1.25.
  • Company reaffirmed full-year 2026 revenue and earnings guidance following the Q1 2026 results.

Lexicon beats with loss <$0.01 per share and revenue $21.1M vs $8.7M expected

 

Lexicon Pharmaceuticals beats Q1 2026 estimates with loss <$0.01 per share and revenue $21.1M vs $8.7M expected

  • Lexicon reported Q1 2026 net loss of $1 million, complementing loss of less than $0.01 per share.
  • Q1 2026 revenue of $21.1M was driven by milestones from Novo Nordisk under existing collaboration.
  • Novo Nordisk has initiated a Phase 1 trial of obesity candidate LX9851 under its collaboration with Lexicon.
  • Lexicon plans a mid-2026 ZYNQUISTA NDA resubmission as part of its updated pipeline strategy.

Iovance Q1 2026 loss of $0.19 on $71.4M revenue in line, affirms Q2 and 2026 revenue guidance

 

Iovance posts Q1 2026 loss of $0.19 on $71.4M revenue in line, affirms Q2 and 2026 revenue guidance

  • Company guides Q2 2026 product revenue to $86–88 million, maintaining previously issued outlook range.
  • Company maintains full-year 2026 product revenue guidance of $350–370 million, unchanged from prior expectations.
  • Positive initial lifileucel data showed a 40% confirmed objective response rate in metastatic serous endometrial cancer.

Trump Paused Project Freedom After Gulf Allies Reportedly Suspended Base, Airspace Access

 It's no secret that America's Gulf allies bore the brunt of Iran's military retaliation in the wake of Operation Epic Fury. Now there are reports of Washington being brushed back when it comes to ongoing base access in the region.

President Trump abruptly halted plans to support commercial shipping through the Strait of Hormuz after Saudi Arabia suspended US military access to its bases and airspace for the operation, two US officials told NBC. Kuwait is reported to have imposed similar restrictions in wake of being on the receiving end of Iranian missiles.

Prince Sultan Air Base in Saudi Arabia, file image

According to the officials, Trump caught Gulf allies off guard when he announced Project Freedom on Truth Social, triggering anger in Riyadh. Saudi Arabia is said to have responded by informing Washington that US forces would not be permitted to operate aircraft from Prince Sultan Air Base southeast of Riyadh or transit Saudi airspace in support of the mission.

Other Gulf allies were also reportedly surprised by the development, with Drop Site News also reporting Kuwait has made a similar move to cut or restrict base access. According to more details from the NBC report:

In response, the Kingdom informed the U.S. it would not allow the U.S. military to fly aircraft from Prince Sultan Airbase southeast of Riyadh or fly through Saudi airspace to support the effort, the officials said.

A call between Trump and Saudi Crown Prince Mohammed bin Salman did not resolve the issue, the two U.S. officials said, forcing the president to pause Project Freedom in order to restore U.S. military access to the critical airspace.

But here is how Trump framed the pause at the time in a Truth Social post: "Based on the request of Pakistan and other Countries, the tremendous Military Success that we have had during the Campaign against the Country of Iran and, additionally"... and he also said it was necessary "to see whether or not the Agreement can be finalized and signed."

By the following day it became clear that the two sides were no closer to getting to the negotiating table, much less actually inking an agreement to end the war.

The White House is meanwhile denying the main content of the NBC report, with one official insisting that "regional allies were briefed in advance."

Washington seemed genuinely shocked and surprised at the level of retaliation Iran unleashed on the region. Tehran has said it went after American bases in the Gulf, and as punishment for the countries hosting them. The response involved weeks of literally hundreds if not thousands of missiles and drones being launched. These hit oil, gas, and energy infrastructure - as well as radar, airbases, and military outposts.

Follow-up reports have said that well over a dozen US regional bases were decimated and made uninhabitable - something which the Pentagon has sought to downplay or else keep totally under wraps.

https://www.zerohedge.com/geopolitical/trump-paused-project-freedom-after-gulf-ally-reportedly-suspended-base-airspace-access

DoJ may focus on 4 bets in $2.6B oil trade probe

 The US Department of Justice is investigating a series of suspiciously timed oil market trades, focusing on at least four transactions made just before major announcements by US President Donald Trump on the war with Iran.

The DOJ and the Commodity Futures Trading Commission are probing bets totalling more than $2.6 billion placed on falling oil prices shortly before they dropped. According to data obtained by ABC News, on March 23, 15 minutes before Trump said he would delay strikes on Iran's power grid, traders wagered over $500 million on a price drop. On April 7, hours before a temporary ceasefire, $960 million was bet. On April 17, $760 million was wagered minutes before Tehran said the Strait of Hormuz was open. On April 21, $430 million followed.

https://breakingthenews.net/Article/DoJ-may-focus-on-4-bets-in-dollar2.6B-oil-trade-probe/66243407

Amazon Pharmacy to offer new Ozempic pill

 Amazon Pharmacy will start offering Novo Nordisk's Ozempic pill for same-day delivery and pickup through kiosks.

The pill is the only FDA-approved oral GLP-1 medication used to treat type 2 diabetes, controlling blood sugar in patients. Those with a prescription can check availability, prices, and order through Amazon Pharmacy. The lowest price with insurance starts at $25 per month, and $149 for cash-paying customers. The delivery can be received at the doorstep or in an in-office kiosk.

"Amazon Pharmacy continues to provide customers expanded selection and reliable, convenient access to the latest treatments like the Ozempic pill for type 2 diabetes, helping reduce the friction that comes with accessing breakthrough medications," said Vice President and General Manager of Amazon Pharmacy, Tanvi Patel.

https://breakingthenews.net/Article/Amazon-Pharmacy-to-offer-new-Ozempic-pill/66243140